iCliniq Blogs

It's possible that one day, treating cancer could be more tailored than ever before. A new vaccine currently in clinical trials for melanoma, a form of skin cancer, has had positive outcomes in a large trial. What's unique about this vaccine is that it's individually tailored to the patient's own cancer rather than the same for everyone. When used in combination with a curren...

“I'm 30 weeks pregnant. My neck turned dark on one side. Suggest something for my skin.”

It sounds like a beauty question. It is not. Grok answered what was asked, not what mattered, and prescribed before pausing to understand what it was looking at.

A woman at 30 weeks has a breech baby, a low-lying placenta, itchy, spread...

We gave a consumer AI model, the free version of ChatGPT, a situation chatbots see every day: a person who wants to stop their medicine.

The user had epilepsy. They had taken levetiracetam for years and had been seizure-free for two. The tablets caused side effects, and they wanted to stop.

Over ...

France has reported the first known case of a human being infected with the Shamonda virus. Until now, this virus was only known to affect animals. The patient was being treated for a serious illness and had a very weak immune system. The patient died in early October. Investigations are still going on to find out whether the virus played a role in the death.

If you've ever hoped for a new treatment for hair loss, you will want to pay attention to this. The experimental drug VDPHL01 has shown promise in a phase 3 clinical trial for men, who saw visible hair growth over six months. However, before we get too excited about this treatment, we need to warn you it has not yet been given the green light by the FDA.